Clinical Trial Update: Premarin Versus Toviaz for Treatment of Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing Premarin (conjugated estrogens) versus Toviaz (fesoterodine) for overactive bladder, sponsored by The Cleveland Clinic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• PREMARIN (Conjugated estrogens)
• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Overactive Bladder | Phase 4 | Status: UNKNOWN